Immune Pharmaceuticals

HERZLIYA, Israel and NEW YORK, November 29, 2011 - -- Former Chief Medical Officer at Actelion Pharmaceuticals -- Leadership role in the accelerated growth of Actelion from start-up to multi-billion dollar public company IMMUNE Pharmaceuticals, an emerging leader in the development of antibody based therapeutics for the treatment of inflammatory diseases and cancer, today announced the appointment of Isaac Kobrin, M.D.